Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02812524
Title Ipilimumab for Head and Neck Cancer Patients
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Providence Health & Services
Indications

head and neck squamous cell carcinoma

Therapies

Ipilimumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.